Learning and knowledge sharing are fundamental to the LHSS Project. We invite you to search LHSS knowledge products and resources for the latest approaches, insights, and learning in the field of integrated health systems strengthening.
This Catalog allows practitioners to consider which interventions have more robust evidence bases to support their practical application, such as: enhancing worker and supervisor competencies through training, offering nonfinancial incentives for high performers, practicing task sharing to promote cost savings, implementing digital solutions to expand access to services, and reducing costs of procuring and distributing pharmaceutical products.
This primer is designed to help supply chain practitioners in governments, the private sector, donor agencies, and implementing partners understand the value of political economy analysis (PEA) and how it can help improve outcomes when implementing supply chain interventions and reforms.
Join us to learn how thinking and working politically and using political economy analysis or PEA can strengthen efforts to reform health commodity supply chains.
LHSS conducted an assessment of Uzbekistan supply chain management system for COVID-19 and emergency commodities.
This fact sheet provides a summary of activity progress in Central Asia as well as results and impact.
This video captures a November 6, 2020 ceremony in Hanoi which marked the formal start of the LHSS Project’s four-year effort to help the Government of Vietnam implement its social health insurance program. The program covers treatment services for people with HIV, among other essential health services.
Working closely with the Vietnam Social Security (VSS) agency, LHSS will help improve the agency’s capacity to manage the insurance program funds effectively, efficiently, equitably, and with accountability. LHSS will also support Vietnam’s transition to full financial ownership of its HIV and TB responses.
HMED software will improve Vietnam’s capacity to effectively forecast ARV demand, and manage the drugs when they are in the country. Also, engaging drug manufacturers and distributors is crucial to overcoming supply side obstacles.